French registry aims to uncover the hidden prevalence of rare overgrowth diseases
NCT ID NCT05563831
First seen Mar 02, 2026 · Last updated May 22, 2026 · Updated 16 times
Summary
This study created the first French national registry for people with rare overgrowth syndromes caused by PIK3CA gene mutations. Researchers collected clinical and genetic information from 28 children and adults to better understand these conditions and estimate how many people are affected. The goal was to improve knowledge, not to test a treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Translational medicine and Targeted therapies unit, Hôpital Necker Enfants Malades
Paris, 75015, France
Conditions
Explore the condition pages connected to this study.